Archives

by in
Entry Author Date Location
Zafgen’s Obesity Drug Continues to Cut The Fat in Phase 2 Trial 06/22/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Johnson & Johnson’s New Innovation Center Part of Broader Initiative 06/07/13 San Francisco
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
Eleven’s Hybrid Approach Takes Shape With ThromboGenics Pact 05/29/13 Boston
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Third Rock’s Ninepoint Medical Grows Up, Plans $35M Series B 05/16/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Sage Therapeutics Shifts Gears, Focuses on Rare Form of Epilepsy 04/17/13 Boston
East Coast Biotech Roundup: Bristol-Myers, Syros, On-Q-ity, Ziopharm 04/12/13 Boston
MA Venture Firms Lead the Way in Slow Q1 Fundraising 04/08/13 Boston
TARIS Biomedical Receives $12,500,000 New Financing 04/02/13 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of Q1 2013 04/01/13 Boston
East Coast Biotech Roundup: Biogen Idec, Third Rock, T2 Bio, Dart 03/29/13 Boston
Still Waiting for the Ships to Come in at Third Rock Ventures 03/28/13 San Diego
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
Blueprint Medicines Combs Through Genome for the Next Gleevec(s) 03/20/13 Boston
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Kala Pharmaceuticals Receives $11,500,000 Series A Funding Round 03/01/13 Boston
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs 02/28/13 Boston
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
East Coast Life Sciences Roundup: Jounce, Tokai, Lux, & More 02/15/13 National
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Page 4 of 12 « previous page · next page »